Ipca Laboratories Limited
IPCALAB
Pozycja w akcjach
#3404
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Cena akcji
$20.02
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$5.08B
Zmiana (1 dzień)
-1.65%
Zmiana (1 rok)
38.46%
Kraj
IN
Handel Ipca Laboratories Limited (IPCALAB)
Kategoria
Healthcare
Wskaźnik P/B dla Ipca Laboratories Limited (IPCALAB)
Wskaźnik P/B na dzień October 2026 TTM: 6.01
Według najnowszych raportów finansowych i ceny akcji Ipca Laboratories Limited, obecny wskaźnik P/B (TTM) wynosi 6.01. Na koniec 2024 wynosił 4.97.
Historia wskaźnika P/B dla Ipca Laboratories Limited od 2005 do 2026
Wskaźnik P/B na koniec każdego roku
| Rok | Wskaźnik P/B | Zmień |
|---|---|---|
| 2026 (TTM) | 6.01 | 18.32% |
| 2025 | 5.08 | 2.13% |
| 2024 | 4.97 | 41.30% |
| 2023 | 3.52 | -28.52% |
| 2022 | 4.92 | -3.99% |
| 2021 | 5.13 | 5.76% |
| 2020 | 4.85 | 23.20% |
| 2019 | 3.94 | 26.08% |
| 2018 | 3.12 | -2.65% |
| 2017 | 3.21 | -1.40% |
| 2016 | 3.25 | -10.50% |
| 2015 | 3.63 | -33.22% |
| 2014 | 5.44 | 27.37% |
| 2013 | 4.27 | 26.78% |
| 2012 | 3.37 | -6.01% |
| 2011 | 3.58 | -7.79% |
| 2010 | 3.89 | 195.76% |
| 2009 | 1.31 | -49.85% |
| 2008 | 2.62 | -17.46% |
| 2007 | 3.18 | 34.15% |
| 2006 | 2.37 | 2.83% |
| 2005 | 2.30 | 0.00% |
Wskaźnik P/B dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/B | Różnica wskaźnika P/B | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -16.13% |
IN
|
